Towards Healthcare Research & Consulting
U.S. Radiofrequency Ablation Devices for Pain Management Market
Updated Date: 09 June 2026   |   Report Code: 6935

U.S. Radiofrequency Ablation Devices for Pain Management Market Strategic Growth Opportunities

According to Shivani Zoting, who specializes in U.S. radiofrequency ablation devices for pain management market analysis, with 5+ years of experience in market research and industry analysis, the U.S. radiofrequency ablation devices for pain management market is set for strong growth, rising from USD 430.43 billion in 2026 to USD 1174.57 billion by 2035 at an 11.8% CAGR. She highlights chronic pain management and musculoskeletal pain as key application drivers, with minimally invasive and image-guided procedures gaining traction across the U.S. Hospitals and ambulatory surgical centers remain the leading end users, while Medtronic, Boston Scientific, Abbott Laboratories, Avanos Medical, and Stryker drive a highly competitive, innovation-focused landscape.

Last Updated : 09 June 2026 Category: Medical Devices Insight Code: 6935 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • U.S. Radiofrequency Ablation Devices for Pain Management Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Radiofrequency Ablation Devices for Pain Management Analysis, By Therapeutic Application
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Radiofrequency Ablation Devices for Pain Management Market Analysis, By Pain Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Radiofrequency Ablation Devices for Pain Management Analysis,By End User
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Radiofrequency Ablation Devices for Pain Management Analysis, By Technology
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • U.S. Radiofrequency Ablation Devices for Pain Management Market Analysis, By Procedure TYpe
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Therapeutic Application
      • By Pain Type
      • By End User
      • By Technology
      • By Procedure Type
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Medtronic
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Boston Scientific
    • Abbott Laboratories
    • Avanos Medical
    • Stryker Corporation

FAQ's

Answer : The U.S. radiofrequency ablation devices for pain management market currently in 2026 records USD 430.43 million and is anticipated to grow to USD 1174.57 million by 2035, advancing at a CAGR of 11.8% from 2026 to 2035.

Answer : National Institutes of Health, FDA, WHO, PIB, CDC.

Answer : Key companies operating in the market include Medtronic, Boston Scientific, Abbott Laboratories, Avanos Medical, Stryker Corporation, NeuroOne Medical Technologies, Merit Medical Systems, Siemens Healthineers, and Stratus Medical.

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar